Your session is about to expire
← Back to Search
LungTalk for Increasing Lung Cancer Screening
N/A
Recruiting
Led By Lisa Carter-Bawa, PhD
Research Sponsored by Hackensack Meridian Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Individuals who currently smoke or quit smoking within the past 15 years
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 6 months from baseline survey completion
Awards & highlights
Study Summary
This trial aims to use innovative methods & designs to increase uptake of lung cancer screening among appropriate, high-risk individuals nationwide. #LungCancerScreening
Who is the study for?
The INSPIRE-Lung Study is for individuals who have a history of heavy smoking (at least 20 pack-years), including current smokers or those who quit within the last 15 years. It's not for people who've already had lung cancer screening, are being monitored for lung nodules, have been diagnosed with lung cancer, or have impaired decision-making.Check my eligibility
What is being tested?
This study tests 'LungTalk', a communication intervention aimed at increasing lung cancer screening rates among high-risk groups using Facebook-targeted advertisements. It compares LungTalk to standard practices without tailored interventions.See study design
What are the potential side effects?
Since this trial focuses on communication strategies rather than medical treatments, there are no direct side effects like you'd expect from drugs or surgeries. However, participants may experience emotional or psychological responses to the content.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a current smoker or quit smoking within the last 15 years.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at 6 months from baseline survey completion
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 6 months from baseline survey completion
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Effectiveness of LungTalk - Knowledge Assessment
Effectiveness of LungTalk - Occurrence of a Patient-Clinician Discussion
Effectiveness of LungTalk - Perceived Barriers
+7 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Tailored health communication intervention (LungTalk)Experimental Treatment1 Intervention
Participants will receive the tailored health intervention "LungTalk". LungTalk is a 10-15 minute long computer-tailored health communication and decision-making tool that is theoretically grounded in the Conceptual Model on Lung Cancer Screening Participation.
Group II: Non-tailored InterventionActive Control1 Intervention
Participants will receive non-tailored American Cancer Society (ACS) Lung Screening Informational Video as per standard of care. ACS Lung Screening Informational Video (ACS LSIV) is a non-tailored 5-minute video from the American Cancer Society about lung cancer screening designed for the lay individual.
Find a Location
Who is running the clinical trial?
Hackensack Meridian HealthLead Sponsor
131 Previous Clinical Trials
27,744 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,669 Previous Clinical Trials
40,925,901 Total Patients Enrolled
Lisa Carter-Bawa, PhDPrincipal InvestigatorHackensack Meridian Health
2 Previous Clinical Trials
120 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am capable of making my own decisions.I have had a low-dose CT scan for lung cancer and am being monitored for lung nodules.You have smoked an average of one pack a day for 20 years or more.I have been diagnosed with lung cancer.I am a current smoker or quit smoking within the last 15 years.
Research Study Groups:
This trial has the following groups:- Group 1: Tailored health communication intervention (LungTalk)
- Group 2: Non-tailored Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Can older adults aged 55 and above join this clinical experiment?
"This clinical trial is targeting patients between the ages of 50 and 80. Interestingly, there are 43 trials for people under 18 years old and 1,609 studies for those above 65."
Answered by AI
Are volunteers still being enrolled in this experiment?
"Based on information hosted by clinicaltrials.gov, this research is actively recruiting participants with the trial having been initially posted and then last edited on August 2nd 2023."
Answered by AI
Am I a suitable candidate to join this medical experiment?
"This research is recruiting 500 individuals aged 50 to 80 who have lung cancer and ≥20-pack-year smoking history, including those that recently quit."
Answered by AI
To what extent is enrollment in this medical experiment progressing?
"Affirmative. Clinicaltrials.gov has documented that this clinical trial, which was initially posted on August 2nd 2023, is actively searching for participants. Approximately 500 patients must be enlisted from 1 medical facility."
Answered by AI
Recent research and studies
Family PracticeJournal
A Qualitative Study Exploring Why Individuals Opt Out of Lung Cancer ScreeningOther Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger